EA
TNDM icon

Emerald Advisers’s Tandem Diabetes Care TNDM Stock Holding History

Emerald Advisers’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-298,210
Closed -$14.3M – 262
2022
Q3 		$14.3M Sell
298,210
-102,721
-26% -$5.63M 0.74% 59
2022
Q2 		$23.7M Buy
+400,931
New +$32.9M 1.22% 24
2020
Q2 		– Sell
-244,310
Closed -$15.7M – 337
2020
Q1 		$15.7M Sell
244,310
-127,694
-34% -$8.95M 0.91% 36
2019
Q4 		$22.2M Sell
372,004
-179,851
-33% -$11.1M 0.94% 38
2019
Q3 		$32.5M Sell
551,855
-35,805
-6% -$2.29M 1.52% 17
2019
Q2 		$37.9M Sell
587,660
-5,180
-0.9% -$334K 1.52% 16
2019
Q1 		$37.6M Sell
592,840
-179,253
-23% -$9.42M 1.53% 10
2018
Q4 		$29.3M Buy
772,093
+143,587
+23% +$5.07M 1.44% 11
2018
Q3 		$26.9M Sell
628,506
-174,010
-22% -$6.08M 0.99% 26
2018
Q2 		$17.7M Buy
+802,516
New +$9.87M 0.67% 68
2014
Q3 		– Sell
-182
Closed -$30K – 409
2014
Q2 		$30K Sell
182
-5,405
-97% -$920K ﹤0.01% 400
2014
Q1 		$1.23M Buy
5,587
+1,160
+26% +$296K 0.07% 238
2013
Q4 		$1.14M Buy
+4,427
New +$1.01M 0.06% 236

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Emerald Advisers's TNDM Position: Q4 2022 in Review

Emerald Advisers sold out of Tandem Diabetes Care (TNDM) in Q4 2022, closing a stake of 298,210 shares — an estimated $14.3M sold.

Emerald Advisers first reported a position in TNDM in Q4 2013 and held it in 13 quarters. The position peaked at $37.9M in Q2 2019. 295 funds tracked by Wall St. Rank hold TNDM as of Q4 2022.

  • Emerald Advisers reported no remaining Tandem Diabetes Care position as of Q4 2022 after selling out during the quarter.
  • Emerald Advisers sold 298,210 Tandem Diabetes Care shares in Q4 2022, an estimated $14.3M.
  • Emerald Advisers first reported a position in Tandem Diabetes Care in Q4 2013 and held it in 13 quarters.
  • Emerald Advisers's Tandem Diabetes Care position peaked at $37.9M in Q2 2019.
  • 295 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2022.

Based on Emerald Advisers's 13F filing for Q4 2022, filed 3 Feb 2023.